# Element Solutions Inc: Form 10-Q for the period ended Mar 31, 2018

- Company: [Element Solutions Inc](/companies/esi.md) (CIK 1590714)
- Form: 10-Q
- Filed: 2018-05-03
- Accepted by EDGAR: May 3, 2018, 16:10 ET
- Period: 2018-03-31
- Accession: 0001590714-18-000053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590714/000159071418000053/pah10-q2018331document.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590714/000159071418000053/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2018-01-01 to 2018-03-31 | $404.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-01-01 to 2018-03-31 | $23.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-01-01 to 2018-03-31 | $277.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-01-01 to 2018-03-31 | $104.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-01-01 to 2018-03-31 | $65.0m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-01-01 to 2018-03-31 | 293,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2018-01-01 to 2018-03-31 | −$161.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2018-01-01 to 2018-03-31 | $10.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-03-31 | $412.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $2.55bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-03-31 | $10.55bn | us-gaap:Assets |
| Current liabilities | at 2018-03-31 | $1.24bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-03-31 | $7.58bn | us-gaap:Liabilities |
| Current portion of debt | at 2018-03-31 | $116.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-03-31 | $2.86bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,671 characters.

*This Management's Discussion and Analysis of Financial Condition and Results of Operations section should be read in conjunction with the unaudited interim Condensed Consolidated Financial Statements and notes thereto included in this Quarterly Report. The following “Overview” section is a brief presentation of our business and certain significant items addressed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations section or elsewhere in this Quarterly Report. You should read this section and the relevant portions of this Quarterly Report for a complete discussion of the events and items summarized below.*

### Overview

#### Our Business

Platform, incorporated in Delaware in January 2014, is a global and diversified producer of high technology specialty chemical products. Our business involves the blending of a number of key ingredients to produce proprietary formulations. Utilizing our strong industry insight, process know-how, and creative research and development, we also partner with our customers to provide innovative and differentiated solutions that are integral to their finished products. We operate in a wide variety of attractive niche markets across multiple industries, including automotive, agriculture, animal health, electronics, graphics, and offshore oil and gas production and drilling, and we believe that the majority of our operations hold strong positions in the product markets they serve. Our product innovations and product extensions are expected to continue to drive sales growth in both new and existing markets, while also expanding margins by continuing to offer high customer value propositions.

We have strong market positions in niche segments of high-growth markets and continually seek opportunities to act as an acquirer and consolidator of specialty chemical businesses, particularly those meeting our “Asset-Lite, High-Touch” philosophy, which involves prioritizing resources to research and development and offering highly technical sales and customer service, while managing conservatively our investments in fixed assets and capital expenditures. We regularly review acquisition opportunities and may acquire businesses that meet our acquisition criteria when we deem it to be financially prudent.

We generate revenue through the formulation and sale of our dynamic chemistries. In addition, we provide highly technical service to our customers through our extensive global network of specially-trained service personnel. Our personnel follow up closely with our customers to ensure that the functional performance of our intricate chemical composition is maintained as intended and that these products are applied safely and effectively. Our specialty chemicals and processes are seen as integral to our customer’s product performance. We leverage these close customer relationships to execute our growth strategy and identify opportunities for new products. These new products are developed and created by drawing upon our intellectual property portfolio and technical expertise. We believe that our customers place significant value on our brands, which we capitalize on through innovation, product leadership and customer service.

#### Our Segments

Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. Both segments share a common focus on attractive niche markets, which we believe will grow faster than the diverse end-markets we serve.

**Performance Solutions** - The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, electronics, commercial packaging and printing, and oil and gas production and drilling. Its products include surface and coating materials, water-based hydraulic control fluids, and photopolymers. In conjunction with the sale of its products, the segment provides extensive technical service and support when necessary to ensure superior performance of their application. While the segment's dynamic chemistries typically represent only a small portion of its customers’ costs, we believe that they are critical to its customers’ manufacturing processes and overall product performance. Further, operational risks and switching costs make it difficult for its customers to change suppliers and allow it to retain customers and maintain its market positions.

The segment provides specialty chemical solutions through the following five businesses:

|  |  |
| --- | --- |
| Assembly Solutions: | The business develops, manufactures and sells innovative interconnected materials, primarily in the electronics market, used to assemble printed circuit boards and advanced semiconductor packaging. |
| Electronics Solutions: | The business designs and formulates a complete line of proprietary “wet” dynamic chemistries used by customers to process the surface of printed circuit boards and other electronic components they manufacture. |
| Industrial Solutions | The business' dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. |
| Graphics Solutions: | The business produces photopolymers, through an extensive line of flexographic plates, which are used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, the segment produces photopolymer printing plates for the flexographic and letterpress newspaper and publications markets. |
| Offshore Solutions: | The business produces water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications. |

**Agricultural Solutions** - The Agricultural Solutions segment specializes in the development, formulation, registration, marketing and distribution of differentiated Crop Protection solutions, including BioSolutions and Seed Treatment, for a variety of crops and applications. The segment's diverse Crop Protection chemicals control biotic stresses, such as weeds (herbicides), insects (insecticides) and diseases (fungicides). Its portfolio of proven BioSolutions includes BioStimulants, which are derived from natural substances applied to plants, seeds or the soil in order to enhance yields and help crops withstand abiotic stress, such as drought or cold, and BioControl products, which perform the same task as conventional Crop Protection products with, in many cases, the added benefit of reduced chemical residues. The segment's solutions are offered in multiple forms, such as foliar applications (direct application to leaves), furrow treatment (treatment of soil trenches or grooves wherein seeds are sown) or Seed Treatment (seed coating prior to planting). Its products allow it to partner with growers to address the ever-increasing need for higher crop yield and food quality.

The segment categorizes its products in three core portfolios:

|  |  |
| --- | --- |
| Crop Protection: | The Crop Protection business is one of the largest Crop Protection chemical companies by revenue. Its diverse Crop Protection chemicals control biotic stresses, such as diseases (fungicides), weeds (herbicides) and insects (insecticides). |
| BioSolutions: | The segment believes its BioSolutions business has a strong position as innovator in BioSolutions and BioStimulants. These products are derived from natural sources that fall into several categories: biological stimulants (BioStimulants), Innovative Nutrition and biological control (BioControl). This portfolio is highly differentiated through innovative technologies and mixtures and primarily protected by trade secrets. |
| Seed Treatment: | The segment's diverse Seed Treatments are applied before planting by coating the seed in order to protect it during germination and protect the plant during its initial growth phases. The segment anticipates growth in Seed Treatments as a result of the increasing value of seeds and the use of higher-value genetically-modified seeds. |

### Proposed Separation of Agricultural Solutions

We previously announced our intention to separate our Agricultural Solutions and Performance Solutions businesses. We believe this Proposed Separation, which we expect to complete in 2018, should maximize long-term value for our stockholders by enabling investors to focus on our specific and differentiated high-quality businesses that serve two distinct segments of the specialty chemicals industry. However, this Proposed Separation, and any related transactions that we may decide to pursue in anticipation of the Proposed Separation, remain subject to final approval by the Board, as well as a number of conditions and variables, including financial market conditions and volatility, legal, tax or regulatory requirements, the establishment of the necessary corporate infrastructure and processes, and/or the possibility of more attractive strategic options arising in the future.

### Recent Accounting Pronouncements

A summary of recent accounting pronouncements in included in Note 2, *Recent Accounting Pronouncements*, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.

### Results of Operations - Three months ended March 31, 2018 as compared to the three months ended March 31, 2017

The following table summarizes our results of operations for the three months ended March 31, 2018 and 2017:

*($ amounts in millions)*

|  | Three Months Ended March 31, 2018 | 2017 | % Change Reported | Constant Currency | Organic |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Net sales** | $964.1 | $861.8 | 12% | 5% | 5% |
| Cost of sales | 559.4 | 483.4 | 16% | 9% |  |
| **Gross profit** | 404.7 | 378.4 | 7% | —% |  |
| Selling, technical, general and administrative | 277.0 | 257.4 | 8% | 3% |  |
| Research and development | 23.5 | 21.6 | 9% | 6% |  |
| **Operating profit** | 104.2 | 99.4 | 5% | (9)% |  |
| Interest expense, net | (78.2) | (89.4) | (13)% |  |  |
| Foreign exchange gain (loss) | 58.0 | (12.6) | nm |  |  |
| Other income (expense), net | 19.0 | (2.3) | nm |  |  |
| Income tax expense | (65.0) | (18.7) | nm |  |  |
| **Net income (loss)** | $38.0 | $(23.6) | nm |  |  |

#### (nm) Calculation not meaningful.

### Non-GAAP Financial Measures

To supplement our financial results presented in accordance with GAAP in this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, we present certain non-GAAP financial measures, such as operating results on a constant currency basis and organic sales growth. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis in terms of absolute performance, trends and expected future performance with respect to our business. We believe these non-GAAP financial measures, which are each further described below, provide investors with an additional perspective on trends and underlying operating results on a period-to-period comparable basis. We also believe that investors find this information helpful in understanding the ongoing performance of our operations separate from items that may have a disproportionate positive or negative impact on our financial results in any particular period or are considered to be costs associated with our capital structure.

These non-GAAP financial measures, however, have limitations as analytical tools, and should not be considered in isolation from, or a substitute for, or superior to, the related financial information that we report in accordance with GAAP. The principal limitations of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements, and may not be comparable to similarly titled measures of other companies due to potential differences in the method of calculation between companies. In addition, these measures are subject to inherent limitations as they reflect the exercise of judgment by management about which items are excluded or included in determining these non-GAAP financial measures. Investors are encouraged to review the reconciliations of these non-GAAP financial measures to their most comparable GAAP financial measures included in this Quarterly Report, and not to rely on any single financial measure to evaluate the Company's businesses.

### Constant Currency

We disclose operating results from net sales through operating profit on a constant currency basis by adjusting to exclude the impact of changes due to the translation of foreign currencies of our international locations into U.S. dollars. Management believes this non-GAAP financial information facilitates period-to-period comparison in the analysis of trends in business performance, thereby providing valuable supplemental information regarding our results of operations, consistent with how we internally evaluate our financial results.

The impact of foreign currency translation is calculated by converting our current-period local currency financial results into U.S. dollars using the prior period's exchange rates and comparing these adjusted amounts to our prior period reported results. The difference between actual growth rates and constant currency growth rates represents the impact of foreign currency translation. The foreign exchange impacts on the quarter-to-date results were primarily the result of appreciation in the euro.

### Organic Sales Growth

Organic sales growth is defined as net sales excluding the impact of foreign currency translation, changes due to the price of certain metals, and acquisitions and/ or divestitures, as applicable. Management believes this non-GAAP financial measure provides investors with a more complete understanding of the underlying net sales trends by providing comparable sales over differing periods on a consistent basis.

The following table reconciles GAAP net sales growth to organic sales growth for the three months ended March 31, 2018:

|  | Three Months Ended March 31, 2018 Reported Net Sales Growth | Impact of Currency | Metals | Acquisitions | Organic Sales Growth |
| --- | ---: | ---: | ---: | ---: | ---: |
| Performance Solutions | 10% | (7)% | 1% | —% | 4% |
| Agricultural Solutions | 14% | (7)% | —% | —% | 6% |
| **Total** | 12% | (7)% | —% | —% | 5% |

#### NOTE: Totals may not sum due to rounding.

For the three months ended March 31, 2018, metals pricing had a negative impact on Performance Solutions' and our consolidated results of $2.6 million.

### Net Sales

*($ amounts in millions)*

|  | Three Months Ended March 31, 2018 | 2017 | % Change Reported | Constant Currency | Organic |
| --- | ---: | ---: | ---: | ---: | ---: |
| Performance Solutions | $492.4 | $447.1 | 10% | 3% | 4% |
| Agricultural Solutions | 471.7 | 414.7 | 14% | 6% | 6% |
| **Total** | $964.1 | $861.8 | 12% | 5% | 5% |

Performance Solutions' net sales increased by 10% (3% on a constant currency and 4% on an organic basis). Organic sales growth was driven by strength in our Assembly, Industrial and Electronics businesses, each of which contributed more than 1% of organic sales growth to the segment. Organic sales growth in our Assembly business continued broadly across product lines, particularly solder paste. Our Industrial business benefited from strong growth of surface treatment chemistries in Europe and Asia. Organic sales growth in our Electronics business was driven primarily by higher sales volume across Asia as well as market share gains in North America.

Agricultural Solutions' net sales increased by 14% (6% on a constant currency and organic basis). Organic sales growth was driven by strength in our LATAM, EMEA and NAANZ regions, which contributed 3%, 2% and 1% of organic sales growth, respectively, to the segment. This overall performance was driven by significant growth in LATAM from a late start of the selling season in

Brazil, particularly for row crop products. Our continued geographic expansion into various European markets, most notably in parts of Eastern Europe, Germany and the United Kingdom, and new product introductions across Europe and parts of Latin America also contributed to this quarter's performance. In addition, organic growth in NAANZ was driven by sales of fungicides in the United States and herbicides in Australia. These increases were partially offset by lower sales volumes in parts of Central and Eastern Europe, Canada and Asia.

### Gross Profit

*($ amounts in millions)*

| Gross profit | Three Months Ended March 31, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: |
| Performance Solutions | $211.2 | $196.8 | 7% | 1% |
| Agricultural Solutions | 193.5 | 181.6 | 7% | (2)% |
| **Total** | $404.7 | $378.4 | 7% | —% |
| **Gross margin** |  |  |  |  |
| Performance Solutions | 42.9% | 44.0% | (110) bps | (90) bps |
| Agricultural Solutions | 41.0% | 43.8% | (280) bps | (340) bps |
| **Total** | 42.0% | 43.9% | (190) bps | (210) bps |

Performance Solutions' gross profit increased by 7% (1% at constant currency). The primary driver of the increase in constant currency gross profit was a 3% increase in constant currency sales. This growth was partially offset by margin erosion resulting primarily from unfavorable product mix in our Electronics business, which recorded a lower proportion of high-margin product sales, most notably in Asia, the impact of certain raw material price inflation year-over-year and increases in logistics and warehousing costs resulting from our plant rationalization initiatives.

Agricultural Solutions' gross profit increased by 7% (decreased 2% on a constant currency basis). The constant currency decrease in gross profit was driven primarily by a combination of AI price inflation, which was driven by tighter supply from China, and unfavorable product mix primarily in Asia and NAANZ. Partially offsetting the decrease was a shift towards a more favorable product mix in LATAM and slightly more favorable input pricing in NAANZ.

### Selling, Technical, General and Administrative Expense (STG&A)

*($ amounts in millions)*

| STG&A | Three Months Ended March 31, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: |
| Performance Solutions | $122.8 | $118.7 | 3% | (2)% |
| Agricultural Solutions | 133.3 | 119.0 | 12% | 7% |
| Corporate | 20.9 | 19.7 | 6% | 6% |
| **Total** | $277.0 | $257.4 | 8% | 3% |
| **STG&A as a % of net sales** |  |  |  |  |
| Performance Solutions | 24.9% | 26.5% | (160) bps | (140) bps |
| Agricultural Solutions | 28.3% | 28.7% | (40) bps | 20 bps |
| **Total** | 28.7% | 29.9% | (120) bps | (60) bps |

28

Performance Solutions' STG&A increased by 3% (decreased 2% on a constant currency basis). The decrease in constant currency STG&A expense was the result of higher costs in the prior year associated with the integration of prior acquisitions and restructuring, partially offset by operating cost inflation.

Agricultural Solutions' STG&A increased by 12% (7% at constant currency). The constant currency increase in STG&A expenses is mostly attributable to higher year-over-year incentive compensation expense, operating cost inflation and costs associated with continued expansion in certain European markets.

Corporate STG&A increased by 6% on a reported and constant currency basis. The increase was primarily due to higher professional fees associated with the Proposed Separation of our Agricultural Solutions business, offset in part by senior executive severance costs incurred in 2017.

### Research and Development Expense (R&D)

*($ amounts in millions)*

| R&D | Three Months Ended March 31, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: |
| Performance Solutions | $11.4 | $11.0 | 4% | 3% |
| Agricultural Solutions | 12.1 | 10.6 | 14% | 10% |
| **Total** | $23.5 | $21.6 | 9% | 6% |
| **R&D as a % of net sales** |  |  |  |  |
| Performance Solutions | 2.3% | 2.4% | (10) bps | 0 bps |
| Agricultural Solutions | 2.6% | 2.6% | 0 bps | 10 bps |
| **Total** | 2.4% | 2.5% | (10) bps | 0 bps |

### Operating Profit

*($ amounts in millions)*

| Operating profit | Three Months Ended March 31, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: |
| Performance Solutions | $77.0 | $67.2 | 15% | 7% |
| Agricultural Solutions | 48.1 | 51.9 | (7)% | (25)% |
| Corporate | (20.9) | (19.7) | 6% | 6% |
| **Total** | $104.2 | $99.4 | 5% | (9)% |
| **Operating margin** |  |  |  |  |
| Performance Solutions | 15.6% | 15.0% | 60 bps | 50 bps |
| Agricultural Solutions | 10.2% | 12.5% | (230) bps | (370) bps |
| **Total** | 10.8% | 11.5% | (70) bps | (160) bps |

Performance Solutions' operating profit increased by 15% (7% at constant currency), representing an operating margin of 15.6%. The increase in constant currency operating profit was driven primarily by lower STG&A expenses and higher gross profit noted above.

Agricultural Solutions' operating profit decreased by 7% (25% at constant currency), representing an operating margin of 10.2%. The decrease in constant currency operating profit was driven primarily by the higher STG&A expenses and lower gross profit noted above.

### Total Other (Expense) Income

*(amounts in millions)*

|  | Three Months Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Interest expense, net | $(78.2) | $(89.4) |
| Foreign exchange gain (loss) | 58.0 | (12.6) |
| Other income (expense), net | 19.0 | (2.3) |
| **Total** | $(1.2) | $(104.3) |

#### Interest Expense, Net

For the three months ended March 31, 2018 and 2017, net interest expense totaled $78.2 million and $89.4 million, respectively, representing a decrease of $11.2 million. The decrease in net interest expense is primarily due to the redemption of our 10.375% senior notes and the repricing of a portion of our term loans in 2017, which decreased the weighted average effective interest rate on our Senior Notes from approximately 7.8% at March 31, 2017 to 6.5% at March 31, 2018, and our term loans from approximately 5.7% at March 31, 2017 to 4.6% at March 31, 2018.

#### Foreign Exchange Gain (Loss)

For the three months ended March 31, 2018 and 2017, foreign exchange gain totaled $58.0 million compared to a loss of $12.6 million, respectively. This year-over-year change is primarily related to the remeasurement of intercompany balances, primarily denominated in Japanese yen, and foreign denominated debt to U.S. dollar.

#### Other income (expense), net

For the three months ended March 31, 2018 and 2017, net other income (expense) totaled $19.0 million and $(2.3) million, respectively. This year-over-year change is primarily related to a gain on the sale of an equity investment of $11.3 million, a $4.8 million favorable adjustment to our ARO reserve for a facility which is in the process of closing in connection with a previously terminated supply agreement related to the CAS Acquisition, as current cost estimates are lower than initially projected, as well as a $3.7 million insurance gain.

### Income Tax

*(amounts in millions)*

|  | Three Months Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Income tax expense | $(65.0) | $(18.7) |
| Effective tax rate | 63.1% | (381.6)% |

For the three months ended March 31, 2018 and 2017, income tax expense totaled $65.0 million and $18.7 million, respectively. The increase in income tax expense was largely driven by an increase in pre-tax income and changes in uncertain tax positions.

### Other Comprehensive Income

Other comprehensive income for the three months ended March 31, 2018 totaled $65.3 million, as compared to $182 million in the prior year. The change was driven primarily by foreign currency translation losses associated with the Canadian dollar and Brazilian real, partially offset by gains associated with the Chinese yuan and euro.

### Segment Performance

Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. Both segments share a common focus on attractive niche markets, which we believe will grow faster than the diverse end-markets we serve. For additional information regarding our segments, see Item 2, *Management’s Discussion and Analysis of Financial Condition and Results of Operations*, under the heading "*Overview,*" and Note 16, *Segment Information,* to our unaudited interim Condensed Consolidated Financial Statements, both included in this Quarterly Report.

### Adjusted EBITDA

We utilize Adjusted EBITDA as one of the measures to evaluate the performance of our operating segments. Adjusted EBITDA for each segment includes an allocation of corporate costs, such as compensation expense and professional fees. See Note 16, *Segment Information*, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report, for more information and a reconciliation of Net income (loss) attributable to common stockholders to Adjusted EBITDA.

*($ amounts in millions)*

| Adjusted EBITDA: | Three Months Ended March 31, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: |
| Performance Solutions | $111.8 | $102.3 | 9% | 2% |
| Agricultural Solutions | 95.4 | 90.8 | 5% | (8)% |
| **Total** | $207.2 | $193.1 | 7% | (3)% |
| **Adjusted EBITDA as a % of net sales** |  |  |  |  |
| Performance Solutions | 22.7% | 22.9% | (20) bps | (30) bps |
| Agricultural Solutions | 20.2% | 21.9% | (170) bps | (290) bps |
| **Total** | 21.5% | 22.4% | (90) bps | (160) bps |

Performance Solutions' Adjusted EBITDA increased 9% (2% at constant currency). The constant currency increase was driven primarily by gross profit growth in our Assembly and Electronics businesses and decreases in integration and restructuring cots related to prior acquisitions. The increase was partially offset by moderate operating cost inflation noted above.

Agricultural Solutions' Adjusted EBITDA increased 5% (decreased 8% at constant currency). The constant currency decrease was driven primarily by the higher STG&A expenses and lower gross profit noted above.

### Liquidity and Capital Resources

At March 31, 2018, our indebtedness totaled $5.61 billion, of which $1.35 billion of term loans under our Amended and Restated Credit Agreement becomes due in 2020. As a result of our interest rate swaps, approximately 67% of our debt is fixed, with the remaining balance subject to fluctuations in the one-month LIBOR and EURIBOR. The expected interest payments on our senior notes and term loans total approximately $275 million per year over the next two years.

Our primary sources of liquidity during the three months ended March 31, 2018 were periodic borrowings under our Revolving Credit Facility and available cash generated from operations. Our primary uses of cash and cash equivalents were to fund operations, working capital, capital expenditures and debt service obligations. We believe that our cash and cash equivalents and cash generated from operations, supplemented by availability under our lines of credit, including our Revolving Credit Facility, will be sufficient to meet our working capital needs, interest payments, capital expenditures and other business requirements for at least the next twelve months. However, working capital cycles and future acquisitions may require additional funding, which may include proceeds from future debt and/or equity offerings. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt and raise equity under term that are favorable to us.

During the three months ended March 31, 2018, approximately 84% of our net sales was generated from non-U.S. operations. We expect to continue to generate significant revenue from non-U.S. operations and, as a result, have a substantial portion of our cash held predominately by our foreign subsidiaries. We expect to manage our worldwide cash requirements based on available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We may transfer cash from certain international subsidiaries to the United States and other international subsidiaries when we believe it is cost effective to do so.

We continually review our domestic and foreign cash profile, expected future cash generation and investment opportunities, which support our current designation of a portion of these funds as being indefinitely reinvested and reassess whether there is a demonstrated need to repatriate funds held internationally. If, as a result of our review, it is determined that all or a portion of the funds require repatriation, we may be required to accrue additional foreign taxes. Of our $413 million of cash and cash equivalents at March 31, 2018, $389 million were held by our foreign subsidiaries.

We may from time to time seek to retire or repurchase our outstanding debt, including, but not limited to, our Senior Notes, through cash purchases and/or exchanges for equity securities, in open market purchases, privately negotiated transactions, or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, applicable restrictions under our various financing arrangements and other factors.

The following is a summary of our cash flows (used in) provided by operating, investing, and financing activities during the periods indicated:

*(amounts in millions)*

|  | Three Months Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| **Cash, cash equivalents and restricted cash, beginning of the period** | **$483.9** | **$423.5** |
| Cash used in operating activities | (161.1) | (119.4) |
| Cash provided by (used in) investing activities | 6.8 | (25.3) |
| Cash provided by financing activities | 74.2 | 78.9 |
| Exchange rate impact on cash, cash equivalents and restricted cash | 14.1 | 9.6 |
| **Cash, cash equivalents and restricted cash, end of the period** | **$417.9** | **$367.3** |

### Operating Activities

During the three months ended March 31, 2018, cash used in operating activities totaled $161 million, compared to $119 million of cash used in operating activity during the three months ended March 31, 2017. This $41.7 million increase in cash used in operating activities was driven primarily by lower cash operating profits (net income (loss) adjusted for non-cash items). Changes in assets and liabilities had a modest decrease, with unfavorable cash flows from higher accounts receivable and inventory balances mainly driven by the timing of sales within our Agricultural Solutions segment, being offset by higher accrued expenses, primarily associated with accrued income taxes, and lower cash interest costs resulting from our debt refinancing activity in 2017.

### Investing Activities

Cash flows provided by investing activities totaled $6.8 million during the three months ended March 31, 2018, as compared to $25.3 million used during the three months ended March 31, 2017. The $32.1 million increase was driven primarily by $25.0 million of proceeds from the sale of an equity investment and $10.0 million of higher proceeds from the beneficial interests of our nonrecourse factoring arrangements as the primary program with this feature was not in place during the first quarter of 2017, and $4.9 million of lower capital expenditures.

### Financing Activities

Cash flows provided by financing activities totaled $74.2 million during the three months ended March 31, 2018, as compared to $78.9 million of cash flows provided by financing activity during the three months ended March 31, 2017. This $4.7 million decrease was primarily driven by lower year-over-year borrowings under our lines of credit of $14.5 million, offset in part by $9.0 million of lower year-over-year debt repayments.

### Financial Borrowings

### Credit Facilities

At March 31, 2018, we had $5.61 billion of indebtedness, which primarily included:

- $2.30 billion of Senior Notes;
- $3.19 billion of term debt arrangements outstanding under our First Lien Credit Facility; and
- $103 million of borrowings under local and revolving lines of credit.

Availability under our Revolving Credit Facility and various lines of credit and overdraft facilities totaled $552 million at March 31, 2018 (including $24.8 million of stand-by letters of credit which reduced the borrowings available under our Revolving Credit Facility).

### Covenants

Our Credit Facilities contain various affirmative and negative covenants, including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, and dispositions. Our Revolving Credit Facility requires compliance with certain financial covenants, including a first lien net leverage ratio of no greater than 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters; provided that in the event that the Company or certain of its subsidiaries (i) incur incremental facilities in an aggregate amount in excess of $250 million or (ii) make restricted payments in an aggregate amount in excess of $50 million, the first lien net leverage ratio will be reduced to 4.00 to 1.0, in each case subject to a right to cure. In addition, our Amended and Restated Credit Agreement requires a prepayment percentage in the case of excess cash flow, both calculated as set forth in the Amended and Restated Credit Agreement, of 75% with step-downs to 50%, 25% and 0% based on the applicable first lien net leverage ratio on the prepayment date.

Lastly, our Senior Notes are governed by indentures which also provide, among other things, for customary affirmative and negative covenants, events of default, and other customary provisions.

### Contractual Obligations and Commitments

The contractual obligations and commitments disclosures have not changed materially from those disclosed in our 2017 Annual Report. For a discussion of our contractual obligations and commitments, refer to Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," contained in our 2017 Annual Report.

### Off-Balance Sheet Transactions

We use customary off-balance sheet arrangements, such as non-recourse factoring arrangements, letters of credit and operating leases to finance our business. For additional information regarding non-recourse factoring arrangements and letters of credit, see Note 9, *Debt, Factoring and Customer Financing Arrangements*, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.

As a result of ASU No. 2016-02, “*Leases,”* for fiscal years and interim periods beginning after December 15, 2018, we will be required to record lease liabilities and right-of-use assets for all of our qualifying operating leases that are currently treated as off-balance sheet transactions.

## Market risk

As filed, 335 characters.

The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our 2017 Annual Report. For a discussion of our exposure to market risk, refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our 2017 Annual Report.

## Controls and procedures

As filed, 4,385 characters.

### (a) Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act. As required by Rule 13a-15(b) of the Exchange Act, management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our CEO and CFO have concluded that the Company’s disclosure controls and procedures were not effective due to the previously-reported material weakness in our internal control over financial reporting relating to the accounting for income taxes, as described more fully in Part II, Item 9A, Controls and Procedures, of our 2017 Annual Report.

The material weakness in our internal control relating to the accounting for income taxes continued to exist as of the end of the period covered by this Quarterly Report and our management continues to be actively engaged in implementing the remediation initiatives described in our 2017 Annual Report. Our ongoing remediation efforts to improve, design and implement integrated processes to enhance our internal control over the accounting for income taxes include the implementation of the following previously stated initiatives:

- improving the overall tax provision process; and
- enhancing our income tax controls to include specific activities to assess the accounting for significant complex transactions and other tax related judgments.

While we believe that significant progress continues to be made, additional time is necessary to fully implement and demonstrate the effectiveness of these remediation initiatives and until remediated, the material weakness described above could result in material misstatements of our annual or interim consolidated financial statements that would not be prevented or detected. We are committed to operating effective controls, and management continues to regularly assess the progress and sufficiency of the ongoing initiatives and make adjustments as and when necessary. Our remediation efforts are also subject to ongoing Audit Committee oversight. Our goal is to remediate this material weakness concurrently with the filing of our annual report on Form 10-K for the year ended December 31, 2018.

Notwithstanding the aforementioned material weakness, our management believes that the unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report fairly represent, in all material respects, our results of operations, financial position and cash flows as of and for the periods presented, each in accordance with GAAP. Based in part on our continuing efforts, our CEO and CFO have included their certifications as exhibits to this Quarterly Report.

### (b) Changes to Internal Control Over Financial Reporting

As required by Rule 13a-15(d) under the Exchange Act, our management, including our CEO and CFO, has evaluated the Company’s internal control over financial reporting to determine whether any changes occurred during the quarter covered by this Quarterly Report have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There have been no significant changes in our internal control over financial reporting that occurred during the quarter covered by this Quarterly Report that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 138 characters.

There have been no material changes in the risk factors from those set forth in Part I, Item 1A, “Risk Factors” of our 2017 Annual Report.

Filed May 3, 2018.
Source: SEC EDGAR, the filing index for accession 0001590714-18-000053. Last ingested by Listed: Nov 10, 2026, 23:30 ET. No prices; not investment advice.
